Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
10.1021/acscentsci.7b00028 Summary Keywords ferroptosis, nonalcoholic fatty liver disease, acute liver failure, hepatitis, hepatocellular carcinoma, liver fibrosis Citation Lu Y, Hu J, Chen L, Li S, Yuan M, Tian X, Cao P and Qiu Z (2023) Ferroptosis as an emerging therapeutic target in liver diseases
Is MOTS-c safe for older adults
Canadian-Specific Considerations Canadian researchers benefit from suppliers specifically serving the Canadian market
In the l-carnitine group, 35.4% (17/48) of patients had hyperammonemia
Supplementary Figure 3 contains the replicate experiments used for quantitation, and shows the large difference in secretion between wild-type and mutant proteins
US$ 24.14
US$ 29.15
US$ 27.72
US$ 28.41
US$ 21.09
US$ 21.55
US$ 26.13
US$ 25.44
US$ 25.32
